miltefosine has been researched along with Mast Cell Activation Disease in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurer, M | 1 |
| Magerl, M | 1 |
| Metz, M | 1 |
| Weller, K | 1 |
| Siebenhaar, F | 1 |
1 review available for miltefosine and Mast Cell Activation Disease
| Article | Year |
|---|---|
Miltefosine: a novel treatment option for mast cell-mediated diseases.
Topics: Antineoplastic Agents; Dermatitis, Atopic; Humans; Mast Cells; Mastocytosis; Phosphorylcholine; Urti | 2013 |